Abstract
The in vitro activities of eight antifungal drugs against clinical isolates of Fonsecaea pedrosoi (n = 21), Fonsecaea monophora (n = 25), and Fonsecaea nubica (n = 9) were tested. The resulting MIC(90)s for all strains (n = 55) were as follows, in increasing order: posaconazole, 0.063 microg/ml; itraconazole, 0.125 microg/ml; isavuconazole, 0.25 microg/ml; voriconazole, 0.5 microg/ml; amphotericin B, 2 microg/ml; caspofungin, 2 microg/ml; anidulafungin, 2 microg/ml; and fluconazole, 32 microg/ml.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amphotericin B / pharmacology
-
Anidulafungin
-
Antifungal Agents / pharmacology*
-
Ascomycota / drug effects*
-
Ascomycota / isolation & purification
-
Caspofungin
-
Chromoblastomycosis / drug therapy*
-
Chromoblastomycosis / microbiology*
-
Drug Resistance, Fungal
-
Echinocandins / pharmacology
-
Fluconazole / pharmacology
-
Humans
-
In Vitro Techniques
-
Itraconazole / pharmacology
-
Lipopeptides
-
Microbial Sensitivity Tests
-
Nitriles / pharmacology
-
Pyridines / pharmacology
-
Pyrimidines / pharmacology
-
Triazoles / pharmacology
-
Voriconazole
Substances
-
Antifungal Agents
-
Echinocandins
-
Lipopeptides
-
Nitriles
-
Pyridines
-
Pyrimidines
-
Triazoles
-
Itraconazole
-
isavuconazole
-
posaconazole
-
Amphotericin B
-
Fluconazole
-
Anidulafungin
-
Caspofungin
-
Voriconazole